Aurora $ACB Announces $6M Complementary Private Placement

Aurora Cannabis(TSX: ACB) (OTCQX: ACBFF) (Frankfurt:  21P; WKN: A1C4WM)

Aurora Cannabis Inc. announced that further to the Company’s previously announced $60 million bought deal financing, as announced and upsized on October 10, 2017, the Company has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of  up to 2,000,000 units of the Company at a price of $3.00 per Unit.

Each Unit, free of any commission to Aurora, will be comprised of one common share of the Company and one common share purchase warrant. Each Warrant will be exercisable to acquire one common share for a period of 3 years following the closing date of the Offering at an exercise price of $4.00 per Warrant Share, subject to adjustment in certain events.

If the Offering is subscribed for in full, it will provide Aurora with net proceeds of $6,000,000 due to the special and one-time commission free accommodation reached with its underwriters. The Common Shares and Warrants shall be subject to a 4 month hold period. Closing of the Offering is anticipated to occur at the same time as the closing of the Bought Deal, which is expected on or about November 2, 2017, and is subject to certain conditions, including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Toronto Stock Exchange and the applicable securities regulatory authorities.